The European Green Deal with its Industrial and Pharmaceutical strategies, as well as the EU Digital Strategy set the course towards Europe’s recovery from the disconcerting effects of COVID-19 on the health of citizens and the resilience of the economy. As the severity of the pandemic became evident, so too did the importance of the life sciences and biotechnology sector. Public officials, regulators, and citizens alike looked eagerly to biotech companies to provide solutions.
EuropaBio’s vision document ‘Unleashing the full potential of life sciences and biotechnology in Europe’, which will be presented at the event, outlines eight key pillars for how life sciences and biotechnology will help achieve a healthier, more resilient and sustainable Europe that swiftly recovers from the current crisis and delivers for its citizens, its regions, and its economy.
Join us for this exciting discussion on the future of biotechnology, hear from industry experts on breakthrough innovations and learn how biotechnology can benefit the ambitious EU strategies that set the Union on course for a healthy and sustainable future!